14.66
Theravance Biopharma Inc (TBPH) 最新ニュース
Can Theravance Biopharma Inc. stock deliver consistent earnings growthJuly 2025 Momentum & AI Powered Market Trend Analysis - newser.com
Can Theravance Biopharma Inc. stock attract ESG capital inflowsPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Will a bounce in Theravance Biopharma Inc. offer an exitQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
What to expect from Theravance Biopharma Inc. in the next 30 daysIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
How to escape a deep drawdown in Theravance Biopharma Inc.2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Can Theravance Biopharma Inc. (0TB) stock sustain revenue momentumMarket Risk Report & Reliable Entry Point Trade Alerts - newser.com
Why Theravance Biopharma Inc. (0TB) stock remains stableJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Theravance Biopharma Inc. stock see insider buyingIPO Watch & Weekly High Return Stock Opportunities - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Is Theravance Biopharma Inc. (0TB) stock a momentum leaderPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy? - sharewise.com
What consensus target says about Theravance Biopharma Inc. (0TB) stockPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionWeekly Loss Report & Weekly High Return Forecasts - newser.com
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System - Lelezard
Theravance Biopharma Inc. stock trendline breakdown2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Can Theravance Biopharma Inc. stock maintain operating marginsMarket Risk Analysis & Verified High Yield Trade Plans - newser.com
Why Theravance Biopharma Inc. stock is in analyst buy zoneStop Loss & Momentum Based Trading Signals - newser.com
What indicators show strength in Theravance Biopharma Inc.Market Growth Review & Verified Technical Trade Signals - newser.com
Theravance Biopharma Inc. stock retracement – recovery analysisJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Theravance Biopharma, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025 - Lelezard
Theravance Biopharma (NASDAQ: TBPH) schedules Nov 10 results call at 5 pm EST - Stock Titan
大文字化:
|
ボリューム (24 時間):